Lubica Draberova

Lubica Draberova

Auto-generated profile, based on publicly available information

Lubica Draberova

Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2018 in Immunological Reviews
Verified
Journal Article
Closed access
IHIvana Halova
Ivana Halova
ERElin Rönnberg
Elin Rönnberg
LDLubica Draberova
Lubica Draberova
HVHarissios Vliagoftis
Harissios Vliagoftis
GNGunnar Nilsson
Gunnar Nilsson
PDPetr Draber
Petr Draber

22 September 2021 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
VBViktor Bugajev
Viktor Bugajev
TPTomas Paulenda
Tomas Paulenda
PUPavol Utekal
Pavol Utekal
MMMichal Mrkacek
Michal Mrkacek
IHIvana Halova
Ivana Halova
PDPetr Draber
Petr Draber
Leukotrienes and sphingolipids are critical lipid mediators participating in numerous cellular signal transduction events and developing various disorders, such as bronchial hyperactivity leading to asthma. Enzymatic reactions initiating production of these lipid mediators involve 5-lipoxygenase (5-LO)-mediated conversion of arachidonic acid to leukotrienes and serine palmitoyltransferase (SPT)-mediated de novo synthesis of sphingolipids. Previous studies have shown that ER membrane protein ORMDL3 inhibits the activity of SPT and subsequent sphingolipid synthesis. However, the role of ORMDL3 in the synthesis of leukotrienes is not known. In this study, we used peritoneal-derived mast cells (PDMCs) isolated from ORMDL3 knockout (KO) or control mice and examined their calcium mobilization, degranulation, IκB-α phosphorylation, and TNF-α production. We found that PDMCs with ORMDL3 KO exhibited increased responsiveness to antigen. Detailed lipid analysis showed that compared to wild-type cells, ORMDL3-deficient cells exhibited not only enhanced production of sphingolipids, but also of leukotriene (LT) signaling mediators LTB4, 6t-LTB4, LTC4, LTB5, and 6t-LTB5. The crosstalk between ORMDL3 and 5-LO metabolic pathways was supported by the finding that endogenous ORMDL3 and 5-LO are localized in similar ER domains in human mast cells and that ORMDL3 physically interacts with 5-LO. Further experiments showed that 5-LO also interacts with the long-chain (LC)1 and LC2 subunits of SPT. In agreement with these findings, 5-LO knockdown increased ceramide levels and silencing of SPTLC1 decreased arachidonic acid metabolism to leukotrienes to levels observed upon 5-LO knockdown. These results demonstrate functional crosstalk between the leukotriene and sphingolipid metabolic pathways, leading to the production of lipid signaling mediators.

9 December 2024 in Allergy
Verified
Journal Article
Open access
AHAmy T. Hsu
Amy T. Hsu
VBViktor Bugajev
Viktor Bugajev
TGTimothy A. Gottschalk
Timothy A. Gottschalk
LDLivia Demkova
Livia Demkova
LPLucie Potuckova
Lucie Potuckova
IHIvana Halova
Ivana Halova

1 November 2007 in Cellular Signalling
Verified
Journal Article
Closed access
PDPeter Dráber
Peter Dráber
LDLubica Dráberová
Lubica Dráberová
PHPetr Heneberg
Petr Heneberg
FSFrantisek Smíd
Frantisek Smíd
HFHassan Farghali
Hassan Farghali
PDPetr Draber
Petr Draber

13 November 2018 in Science Signaling
Verified
Journal Article
Closed access
PDF file
IHIvana Halova
Ivana Halova
MBMonika Bambouskova
Monika Bambouskova
LDLubica Draberova
Lubica Draberova
VBViktor Bugajev
Viktor Bugajev
PDPetr Draber
Petr Draber
Mast cell chemotaxis toward prostaglandin E 2 is inhibited by the transmembrane adaptor protein NTAL.